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The combination of ischemia and reperfusion after lung transplantation is 
characterized by endothelial damage, neutrophil sequestration, and decreased 
release of endothelial nitric oxide. Because nitric oxide has been shown to 
selectively dilate the pulmonary vasculature, abrogate neutrophil adherence, 
and restore ndothelial dysfunction, we hypothesized that inhaled nitric oxide 
given for 4 hours during initial reperfusion might attenuate r perfusion i jury 
in a porcine model of left single-lung transplantation. We tested hemodynamic 
and gas exchange data, lung neutrophil sequestration, and pulmonary artery 
endothelial dysfunction after 4 and 24 hours of reperfusion i 12 pigs randomly 
assigned to nitric oxide and control groups. Harvested lungs were preserved in
normal saline solution for 24 hours at 4 ° C. During transplantation, i flatable 
cuffs were placed around each pulmonary artery to allow separate valuation 
of each lung by occluding flow. Compared with the transplanted lungs in the 
control group, transplanted lungs in pigs treated with inhaled nitric oxide 
significantly improved gas exchange, pulmonary vascular esistance, shunt 
fraction, and oxygen delivery at 4 and 24 hours after reperfusion. Neutrophil 
sequestration, as measured by the neutrophil-specific enzyme myeloperoxidase 
and the alveolar leukocyte count per light microscopic field, was significantly 
lower at 24 hours after reperfusion i the transplanted lungs of the nitric oxide 
group. The nitric oxide-treated native right lungs exhibited significantly 
reduced increase in neutrophil accumulation c mpared with that in control 
native right lungs. After 24 hours of reperfusion, endothelium-dependent 
relaxation to acetylcholine was similarly and severely altered in both groups. 
We conclude that short-term inhaled nitric oxide given during the first 4 hours 
of reperfusion after lung transplantation significantly attenuates reperfusion 
injury, improving raft function as long as 24 hours after operation. This effect 
is probably mediated by a decrease in neutrophil sequestration. A protective 
effect on the contralateral lung was also observed. Inhaled nitric oxide may be 
a suitable agent when an acute reperfusion phenomenon is anticipated. 
(J Thorac Cardiovasc Surg 1996;112:590-8) 
E arly death after lung transplantation is mainly a function of ischemia-reperfusion (IR) injury, 
which occurs in about 20% of recipients. 1 This 
complex lung injury is characterized by increased 
pumonary capillary permeability, pulmonary hyper- 
tension, and peripheral leukopenia. 2-4 Endothelial 
damage, the hallmark of this phenomenon, 5 appears 
to be the consequence of pulmonary sequestration 
and activation of polymorphonuclear neutrophils 
(PMNs). 2'3'6 After sudden reoxygenation, toxic 
waste products combine to produce non-neutrophil- 
derived oxygen free radicals. 7' s This leads to endo- 
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thelial adhesion and activation of PMNs. 9 The re- 
lease of inflammatory mediators further enhances 
this process, a° In turn, activated PMNs release re- 
active oxygen species and cytotoxic enzymes, al Pul- 
monary sequestration and activation of PMNs thus 
appear to play a key role in the pathogenesis of IR 
injury. 8 
Inhaled nitric oxide (NO) is being increasingly 
used as a potent selective pulmonary vasodilator, 12
effective in reducing pulmonary artery (PA) pres- 
sure in pulmonary hypertension after lung trans- 
plantation. 13 Endothelial cell dysfunction in IR in- 
jury is manifested by a loss of NO-dependent 
vasodilation 8 and correlates well with increased 
pulmonary vascular esistances after lung transplan- 
tation. 14 A decreased release of endothelial NO is 
observed after reperfusion of transplanted rat 
lungs. ~5 NO has also been shown to decrease PMN 
adherence to reperfused endothelium s and to 
maintain endothelial barrier properties, a6 Previous 
observations by our group have shown that the 
reduction of pulmonary endothelium-dependent 
relaxation seen in IR injury was restored when the 
NO precursor L-arginine was given. 17 In addition, 
inhaled NO was shown to prevent endothelial dys- 
function and PMN accumulation in the isolated 
piglet lung. ~8 NO has also been shown, however, to 
potentiate the harmful effects of IR in some mod- 
els. 19 We therefore tried to confirm the beneficial 
effects of 4 hours of inhaled NO on pulmonary graft 
function and PMN sequestration i a large animal 
model after 4 and 24 hours of reperfusion. We 
tested whether NO (1) prevents an increase in 
pulmonary vascular esistance, (2) improves trans- 
alveolar gas exchange, (3) decreases pulmonary 
PMN sequestration, and (4) attenuates endothelial 
dysfunction 24 hours after lung transplantation. 
Material and methods 
All animals received humane care in compliance with 
the "Principles of Laboratory Animal Care" formulated 
by the National Society for Medical Research and the 
"Guide for the Care and Use of Laboratory Animals" 
prepared by the Institute of Laboratory Animal Resources 
and published by the National Institutes of Health (NIH 
publication No. 86-23, revised 1985). 
Left lung allotransplantation in pigs. Young pigs 
(Large White, n = 24, 25 to 30 weeks of age, 22 to 26 kg) 
were used. They were sedated with intramuscular ket- 
amine (100 mg/kg), anesthetized with intravenous pento- 
barbital (10 mg/kg) followed by a continuous intravenous 
1 1 infusion of 0.1 rag. kg- min- , and paralyzed with pan- 
curonium (0.3 mg/kg). After endotracheal intubation, the 
animals were ventilated with intermittent positive- 
pressure ventilation (MMS 107 ventilator, Chelles, 
France) at a tidal volume of 15 ml/kg, with a respiratory 
rate of 18 cycles/min and a fraction of inspired oxygen 
(Fio2) of 0.5. Body temperature was maintained at 37 ° C 
by means of a heating blanket. 
Pigs were randomly allocated to the NO or control 
group (n = 6 in each group). Mean body weights of donor 
animals were 24.1 _+ 0.7 kg in the control group and 23.5 
_+ 0.9 kg in the NO group (p not significant). In the 
recipient animals, mean body weights were 24.7 -+ 0.8 kg 
and 24.0 + 0.9 kg in control and NO groups, respectively 
(p not significant). 
Donor operation. A median sternotomy was performed 
and the heart-lung block was dissected. After systemic 
heparinization (500 U/kg), a cannula was inserted into the 
main PA. The PA was flushed with 50 ml/kg cold (4 ° C) 
leukocyte-depleted (l ukocyte filters; Pall Corp., Biomed- 
ical Products Div., Glen Cove, N.Y.) Wallworks blood- 
based solution. Ventilation was continued throughout the 
procedure. The trachea was clamped with the lungs 
inflated. The heart-lung block was harvested from right to 
left, to minimize trauma to the left lung. The left lung was 
then dissected from the heart-lung block with a large cuff 
of left atrial tissue and placed in a basin containing 0.9% 
cold saline solution and stored at 4 ° C for 24 hours. 
Recipient operation. The weight-matched pigs were 
sedated and anesthetized with the same procedure used 
for the donor animals. A 750 mg dose of cefamandole was 
given intravenously before incision. A left thoracotomy 
was performed through the fifth intercostal space, and the 
pericardium was opened. The hilum was dissected and an 
inflatable cuff (Phymep, Paris, France) was placed around 
the proximal right PA. Care was taken to place the cuff 
above the most proximal branch. The left pulmonary 
veins, atrium, PA and main bronchus were dissected and 
clamped, and the left lung was removed. The bronchial 
anastomosis was performed first with continuous 4-0 
Prolene suture (Ethicon, Inc., Somerville, N.J.). The left 
atrium was then anastomosed byperforming a horizontal, 
continuous everting mattress uture with 6-0 Prolene 
suture. The PA anastomosis was performed with two 
continuous 6-0 Prolene sutures. A 120 mg dose of methyl- 
prednisolone was administered intravenously. After lung 
inflation, pulmonary circulation was restored. Another 
inflatable cuff was then placed around the left PA, and the 
injection ports connected to each cuff were exteriorized 
through the end of the thoracotomy. The lungs were 
ventilated with 100% Fio 2 and 3 cm H20 positive end- 
expiratory pressure with the previously mentioned vol- 
umes. A chest ube was inserted, and the chest was closed. 
The chest ube was connected to a water-sealed rainage 
device with 20 cm H20 suction, and the animal was placed 
in the prone position. 
Clinical measurements. A Swan-Ganz flow-directed 
thermal-dilution catheter (Baxter Healthcare Corp., Ed- 
wards Division, Irvine, Calif.) was inserted through an 
external jugular vein cutdown and placed in the main PA 
with fluoroscopic guidance. A carotid arterial ine was also 
placed. Both catheters were then connected to Bentley 
800 transducers (Bentley Laboratories, Uden, Holland) 
and systemic arterial pressures and pulmonary arterial 
pressures were continuously monitored, with the zero 
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reference placed at midchest level. Pressures and electro- 
cardiogram were recorded on a Gould Brush 2800 re- 
corder (Gould, Inc., Oxnard, Calif.). Cardiac output (CO) 
was measured in triplicate by thermodilution with an 
Edwards 9502 computer and injection of 5 ml ice-cold 5% 
dextrose solution into the proximal port of the Swan-Ganz 
catheter. Pulmonary compliance was measured by the 
ratio of peak inspiratory pressure to tidal volume. Blood 
gas values (arterial and mixed venous) were measured by 
a blood gas analyzer (ABL 113; Radiometer America, 
Inc., Medical Div., Westlake, Ohio) at 37°C but were 
corrected for each animal's blood temperature. 
Formulas used were as follows: Pulmonary vascular 
resistance (PVR) = Mean PA pressure/CO × 80 (dyne • 
sec • cm-5); Arterial oxygen content = Arterial satura- 
tion × 1.34 × hemoglobin (Hb) + 0.0003 × Arterial 
oxygen tension (Pao2 in ml/dl); venous oxygen content = 
Venous saturation × 1.34 × Hb + 0.0003 × Venous 
oxygen tension (in ml/dl); Alveolar-arterial gradient = 
[Fio2 × (760 - 47)] - arterial carbon dioxide tension -
Pao2 (in mm Hg); Shunt fraction at 100% Fio 2 = (Alve- 
olar oxygen content - Arterial oxygen content)/(Alveolar 
oxygen content - Venous oxygen content) (in %). 
Protocol. NO, supplied as a mixture of NO (300 ppm) 
in nitrogen, was added to the breathing circuit to produce 
an inspired concentration of 30 ppm. The concentrations 
of NO and nitrogen dioxide were assessed by a chemolu- 
minescence method (NO × 2000, Seres, Aix en Provence, 
France) by sampling gas in the inspiratory limb of the 
circuit 2 cm proximal to the endotracheal tube and distally 
at the end of the endotracheal tube. Ventilation with NO 
was started 5 minutes before reperfusion and continued 
for 4 hours. The control group received the same concen- 
tration of nitrogen in the inspired gas through the same 
period. In both groups, lung function was assessed 4 and 
24 hours after reperfusion. This assessment consisted of 
measurement of arterial and mixed-venous gas values, 
pulmonary compliance, and pulmonary and systemic he- 
modynamic values at an Fio 2 of 1.0 under the following 
three conditions: both lungs perfused, native right lung 
only perfused, and transplanted left lung only perfused. 
Each PA was left occluded for 10 minutes before mea- 
surement, and flow was restored for 10 minutes for 
equilibration before proceeding. Positive end-expiratory 
pressure remained the same. At the end of the 4-hour 
period, the animal was awakened and extubated. Twenty- 
four hours after reperfusion, the animal was anesthetized 
again and intubated. A median sternotomy was per- 
formed, and complete hemodynamic and gas exchange 
assessment was done under the same conditions as at 4 
hours. Instead of using the cuffs, direct clamping of each 
PA was done. At autopsy, all anastomoses were inspected 
for stenosis. 
Wet-dry lung weight (W/D) ratio. The native and trans- 
planted lungs were excised and weighed for determination 
of the final wet lung weight. They were then dried in an 
oven at 60 ° C and weighed daily for 30 days or until the 
dry weight was stable for longer than 5 days, to allow 
determination of W/D ratio. 
Leukocyte counts. Absolute and differential leukocyte 
counts were determined with an Argos counter (ABX, 
Paris, France). The automated counts were routinely 
verified by manual countings. The counts, expressed as 
cells per milliliter, were used to calculate the percentage 
of PMNs' decrease as the ratio of difference in the PMN 
count before reperfusion and at 4 or 24 hours after 
reperfusion to the PMN count before perfusion. 
Alveolar leukocytes (histology). At the end of the ex- 
periment, large specimens were taken from the upper and 
lower lobe of each lung and fixed by immersion in 10% 
neutral buffered formalin. After staining with hematoxy- 
lin-eosin, all biopsy samples were examined in a blinded 
fashion. Leukocyte counts were performed with a 40× 
occular and a 10× eyepiece reticule to examine 10 con- 
secutive fields containing only alveoli. 
Myeloperoxidase (MPO) activity. At 24 hours, another 
lung tissue specimen was sampled and snap frozen in 
liquid nitrogen. For determination of baseline values, a 
specimen was taken from the freshly harvested onor 
right lung. MPO, a marker enzyme specific to PMNs, was 
used as an indirect measure of tissue neutrophil infiltra- 
tion. The method described by Mullane, Kraemer, and 
Smith a° was used. Lung tissue was homogenized in 10% 
weight/volume solution of hexadecyltrimethyl ammonium 
bromide buffer (0.5% hexadecyltrimethyl ammonium bro- 
mide in 50 mmol/L phosphate buffer at pH 6.0) with a 
Polytron homogenizer (Kinematica, Luzern, Switzerland). 
The homogenate was sonieated on ice for 15 seconds, 
frozen at -70°C and thawed three times, then centri- 
fuged at 40.000g for 15 minutes. Supernatant was assayed 
spectrophotometrically for MPO activity. A 20/zl portion 
of the supernatant was combined with 12 p~l 25 mmol/L 
hydrogen peroxide, 30/xl 40 mmol/L o-dianisidine hydro- 
chloride, and 1.938 ml 50 mmol/L phosphate buffer (pH 
6.0). The change in absorbance was measured at 460 nm 
on a Beckman spectrometer (model 25 spectrometer; 
Beckman Instruments, Fullerton, Calif.). One unit of 
MPO activity was defined as the activity degrading 1/xmol 
peroxide per minute at 25 ° C. 
Isolated PA ring studies. After autopsy at 24 hours, 
lung specimens were harvested for isolated PA ring stud- 
ies. TM Left and right intrapulmonary artery segments were 
dissected out, cleaned, cut into rings 3 to 4 mm in length 
(1 to 2 mm external diameter), and placed in warmed 
Krebs-Henseleit buffer composed of 118.3 mmol/L so- 
dium chloride, 4.7 mmol/L potassium chloride, 2.5 
mmol/L calcium chloride dihydrate, 1.2 mmol/L potas- 
sium phosphate, 1.2 mmol/L magnesium sulfate heptahy- 
drate, 25 mmol/L sodium bicarbonate, 0.03 mmol/L eth- 
ylenediaminetetraaeetic acid, and 11.1 mmol/L glucose. 
Three to four rings were obtained from each animal. For 
baseline values, rings were also obtained from the freshly 
harvested right donor lungs. 
The rings were then mounted on stainless-steel hooks, 
suspended in 10 ml tissue baths, and connected to force- 
displacement transducers (LB-5; Rikadenki Electronics, 
Freiburg, Germany) to record changes in force with a 
strip-chart recorder (LR 4210; Yokogawa Electric Corp., 
Tokyo, Japan). The baths were filled with 10 ml Krebs- 
Henseleit buffer and aerated at 37 ° C with a gas mixture of 
95% oxygen and 5% carbon dioxide. PA rings were 
initially stretched to produce a preload of 2g force and 
equilibrated for 60 to 90 minutes. A preload of 2g has 
been proved to be optimal for porcine PA rings. TM During 
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Fig. 1. Pao 2 after 4 and 24 hours of reperfusion with 
ventilation at Fio 2 of i and blood flow to the native right 
lung (NL) or to the transplanted left lung (TL) alone, t 
indicates p < 0.001 versus TL at 4 hours in the control 
group; * indicates p < 0.05 versus TL at 24 hours in the 
control group. 
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Fig. 2. PVR after 4 and 24 hours of reperfusion, ventila- 
tion with Fio 2 of 1, and blood flow to the native right lung 
(NL) or to the transplanted left lung (TL) alone. ? 
indicates p < 0.001 versus TL at 4 hours in the control 
group; * indicates p < 0.01 versus TL at 24 hours in the 
control group. 
this period, the Krebs-Henseleit buffer in the tissue baths 
was replaced every 10 minutes. After incubation with 
indomethacin (10 .5 retool/L) for 60 minutes (to exclude 
any interaction with prostanoids), a concentration-re- 
sponse curve to phenylephrine (10 -9 to 3 × 10 4 mmol/L 
final concentration) was obtained. The rings were then 
washed, and the developed force was allowed to return to 
baseline. The rings were precontracted with phenyleph- 
rine at the dose needed to achieve 50% of maximal 
contraction (ECso). Once a stable contraction was ob- 
tained, acetylcholine hyd/ochloride (10 9 to 10 -4 mmol/L 
final concentration) was added to the bath to assess 
changes in endothelium-dependent relaxation. These 
rings were washed again and allowed to equilibrate to 
baseline. The procedure was repeated with sodium nitro- 
prussate, an endothelium-independent vasodilator (10 .5 
mmol/L). In addition to the change in force (in grams), 
responses were assessed by determining the following: (1) 
the ECso and (2) the maximal responses to phenylephrine 
and acetylcholine (gmax) , which were extrapolated from 
the individual concentration-effect curves. Relaxation was 
expressed as the percentage decrease in tension of phe- 
nylephrine-elicited constriction. Acetylcholine hydrochlo- 
ride and indomethacin were purchased from Sigma 
Chemical Co. (St. Louis, Mo.). Phenylephrine and sodium 
nitroprussate were provided by Boehringer Ingelheim 
(Paris, France) and Hoffman-LaRoche & Co AG (Basel, 
Switzerland), respectively. All chemicals were freshly pre- 
pared the day of the experiment. 
Statistical analysis. All values are expressed as the 
mean (_+ standard error of the mean). Statistical analysis 
was performed with the paired Student's t test, two-way 
analysis of variance for repeated measurements, and the 
Newman-Keuls test as a post hoc test when the overall F 
value was significant. Values of p lower than 0.05 were 
considered significant. 
Results 
Both groups were comparable with respect to 
animal weight, duration of cold ischemia (24.0 _+ 0.3 
vs 24.3 _+ 0.2 hours in the control and NO groups, 
respectively), warm ischemia (51 _+ 8 vs 48 _+ 12 
minutes in the control and NO groups, respectively), 
and preoperative blood gases and pulmonary arte- 
rial pressures. Preoperative and postoperative Hb 
values and platelet counts were similar in the two 
groups. At autopsy, one pig was found to have 
thrombosis of the inferior left pulmonary vein and 
was excluded from the study. 
Effect of inhaled NO on lung function and hemo- 
dynamic parameters. Ischemia and subsequent 
reperfusion resulted in marked deterioration of the 
overall function of the transplanted lung. With 
blood flow directed to the transplanted lung alone 
and an Fio 2 of 1, the Pao 2 (Fig. 1) was significantly 
greater in the NO group after 4 and 24 hours of 
reperfusion. Similarly, both PVR (Fig. 2) and shunt 
fraction (Table I) were significantly lower in the NO 
group after 4 and 24 hours of reperfusion. Inhaled 
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Table I. Summary of hemodynamic and gas-exchange measurements at 4 and 24 hours after left lung 
transplantation, ventilation with an inspiratory fraction of 1, with or without reatment with inhaled nitric oxide 
during the first 4 hours of reperfusion and with blood flow to both lungs, native right lung, or transplanted lung 
alone 
After 4 hours of reperfusion After 24 hours of reperfusion 
Control Inhaled nitric oxide Control Inhaled nitric oxide 
2L NL TL 2L NL TL 2L NL TL 2L NL TL 
Pao2 (mm Hg) 
Paco 2 (mmHg)  26±3 
Arterial oxygen 99 ± 0 
saturation (%) 
Venous oxygen 62 ± 6 
saturation (%) 
MPAP (ram Hg) 22 ± 3 
Cao2 (ml/dl) 12 --- 1 
Shunt fraction 17 --- 1 
(%) 
359 +47 435 +33 96--+22 463-+23 463+16405--+31" 283±51 359--88 100±31 367--+35 414±32233_+41?  
26--+2 46--+5 30+3 33--+8 38--+8 36"+13 32 +9 47_+8 23--+2 17.+3 25--+6t 
99-+0 92--+3 99 +0 99--+0 99--+0:~ 98--+i 98 +0 78"+16 99--+0 99- -0  97--+1.4t 
67--+5 27±5 74"+7 71--+5 61±10:~ 48--+4 57"+3 26±11 55±7 52±7 48±9 
22-+3 43+5 14--+3 15--+4 20 +4.  26--+4 26"+5 49--+8 16--+2 16--+2 24±3"  
12±1 10"+1 14±1 13--+1 13"+1:~ 12--+1 13"+1 9--+2 13_+1 13--+1 12±1t  
16±1 39 +8 15--+2 16±2 20±45 22--+2 18±1 52--+18 21±4 23--+4 28±9# 
2L, Both lungs; NL, native lung; TL, transplanted lung; Paco2, arterial carbon dioxide tension; MPAP, mean PA pressure; Cao2, arterial oxygen content. 
Values are mean -+ standard error of the mean. 
*p < 0.001 versus TL in control group. 
tp < 0.05 versus TL in control group. 
Sp < 0.01 versus TL in control group. 
NO did not affect other hemodynamic parameters, 
such as heart rate, systemic pressure, or CO. There 
was a tendency toward a preserved CO in the 
presence of NO (2.1 _+ 0.4 vs 3.2 _+ 0.4 L/min at 4 
hours, and 1.6 _+ 0.5 versus 2.8 _+ 0.3 L/min at 24 
hours); although not statistically significant, it trans- 
lated into a significantly improved oxygen delivery 
value for the transplanted lung at 4 hours (228 _+ 43 
vs 452 _+ 74 ml/min, p < 0.05). 
The W/D ratios for the transplanted lungs were 
comparable in the two groups. W/D ratio was 5.1 _+ 
0.2 in the control group and 4.9 _+ 0.1 in the NO 
group. 
Effect of inhaled NO on pulmonary neutrophil 
sequestration. Inhaled NO was associated with a 
significant reduction in graft neutrophil sequestra- 
tion (Fig. 3). In comparison with NO-treated trans- 
planted left lungs, control transplanted left lungs 
had a significantly higher concentration of neutro- 
phils within their tissue. Furthermore, the control 
right lung exhibited a statistically significant increase 
in MPO value compared with the baseline value, 
whereas the NO-treated right native lungs did not 
exhibit a significant increase from baseline (Fig. 3). 
This points to an injury-preventive effect of NO on 
the native lungs. An indirect parameter of reduced 
neutrophil sequestration, the absolute neutrophil 
count increased significantly in the NO group; such 
an increase did not occur in the control group, 
presumably because of neutrophil sequestration i  
the graft (Fig. 4). Buttressing these findings, histo- 
logic examination of the transplanted lung showed 
massive leukocyte sequestration in the control group 
(170 _+ 48 leukocytes per 10 fields) compared with 
the NO group (40 _+ 8 leukocytes per 10 fields, p < 
0.05). In the native lungs, leukocyte counts per 10 
fields were similar in both groups. 
Effect of inhaled NO on endothelium-dependent 
relaxation of PA rings. After 24 hours of reperfu- 
sion, the relaxant responses to acetylcholine of PA 
rings taken from transplanted and native lungs in 
both groups (as demonstrated by Ema x and ECs0 ) 
were significantly reduced compared with baseline 
values obtained from PA rings derived from freshly 
collected vessels from the flushed right lung of the 
donor (Em~ 46.8% -+ 12.7%; ECso 1.4.10 .7 -+ 0.5 × 
10 -7 mol/L; p < 0.05 versus either group). For the 
transplanted lungs, there were no significant differ- 
ences between the NO and control groups (gmax: 
23.2% -+ 6.06% and 15.8% _+ 9.8%; ECs0 1.7 × 
10 .6 +_ 0.7.10 .6 mol/L and 2.7 × 10 .6 -+ 1.3 × 10 .6 
mol/L for the NO and control groups, respectively; 
Fig. 5). Relaxation responses were not significantly 
different from those of the reperfused native right 
lungs in either group. Endothelium-independent 
relaxation induced by sodium nitroprusside re- 
mained unaltered (ranging from 90% to 100%) and 
equal in both groups. 
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Fig. 3. Lung MPO activity at baseline (freshly harvested 
lungs) or from native lungs (NL) and transplanted lungs 
(TL) after 24 hours of reperfusion. * indicates p < 0.01 
versus TL in the control group; t indicates p < 0.001 TL 
versus baseline within NO group, NL versus baseline, and 
TL versus NL within control group; § indicatesp < 0.0001 
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Fig. 4. Percentage of peripheral blood PMN increase 
after 4 and 24 hours of repeffusion i the control and NO 
groups. * indicatesp < 0.05 versus control group at4 hours. 
Discussion 
This study shows that inhaled NO applied for a 
period of 4 hours after reperfusion attenuates IR 
injury, resulting in improved graft function even after 
withdrawal of NO. This effect is maintained as long as 
24 hours after reperfusion (endpoint of the study). To 
characterize the mechanisms involved in this protec- 
tive effect, two key parameters of IR injury were 
quantified: pulmonary PMN sequestration a d pulmo- 
nary endothelial function. We documented a signifi- 
cant decrease in PMN sequestration in the graft and a 
nonsignificant reduction in endothelial dysfunction. 
The in vivo model used allowed a gas-exchange 
study, one of the most sensitive indicators of trans- 
planted lung function. 6 Direct comparison of the 
transplanted and native lungs was made possible 
through the use of the inflatable cuffs placed around 
each PA. This is a well described and reproducible 
model.2i, 22 Performing a sternotomy at 24 hours 
allowed us to clamp each PA under direct vision, 
thus excluding any technical bias stemming from 
malfunctioning or leaking cuffs. The animals were 
kept to a rigorous functional standard; all were 
extubated after 6 to 7 hours and reintubated the 
next day. This contrasts with acute studies, in which 
animals are kept intubated until the end of the study 
period and then are killed. Furthermore, a 24-hour 
graft cold ischemia period has been previously 
shown to produce significant IR injury. 4 Indeed, 
severe functional alterations and massive pulmonary 
PMN sequestration were consistently observed in 
the transplanted lungs of the control group but not 
those of the NO group. The blood used in the 
Wallwork's solution used for flushing was filtered to 
eliminate leukocytes. This was done to avoid PMN 
sequestration i  the lung during the ischemic pres- 
ervation, which could interfere with PMN measure- 
ments. 
Prevention of IR injury after lung transplantation 
has been studied in different models, including the 
use of free-radical scavengers in the flush solution, 23 
leukocyte-depleted blood, 2 cytokine inhibition with 
pentoxifylline, 22or NO donors. 16" 17 These were all 
overwhelmingly acute studies, with variables mea- 
sured within a 4- to 6-hour period after reperfusion. 
Leukocyte sequestration has also been shown to be 
largely diminished in these models, further pointing 
to the central role of PMNs in IR injury. The clinical 
and practical applicability of some of these tech- 
niques remain questionable, however, in immunosu- 
pressed patients. Our choice to use inhaled NO 
rather than other NO donors was based on the fact 
that gaseous NO can be delivered directly to the 
pulmonary circulation by inhalation. Its short half- 
life is the result of rapid inactivation by Hb, which 
limits its systemic effects and restricts its activity to 
pulmonary tissues. 8 To date, only a few reports have 
been published on inhaled NO in the treatment of 
acute reperfusion injury after lung transplanta- 
tion.a3, 24 Our ,results seem to indicate that inhaled 
NO has a preventive ffect on IR injury and support 
selective pulmonary vasodilatory properties of in- 
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Fig. 5. Acetylcholine-induced ndothelium-dependent re- 
laxation (percentage decrease in tension of phenylephrine- 
elicited contraction) of PA rings derived from left trans- 
planted lungs after ischemia nd 24 hours of reperfusion for 
the NO (closed circles) and control (open circles) groups and 
for the baseline (freshly harvested lungs; tn'angles). * indi- 
catesp < 0.05 baseline versus NO and control group. 
haled NO; no systemic side effects were noted. The 
largest human experience with NO is in the treat- 
ment of acute respiratory distress syndrome, and 
many studies have documented its low toxic side 
effect profile. 25 Furthermore, inhaled NO has also 
been found to be protective against oxidant-induced 
lung injury, a model related to IR injury. 26 
IR injury is an explosive phenomenon that occurs 
within 2.5 minutes of reperfusion in animal mod- 
els, 27 and the first hour of reperfusion is the period 
of higher risk of PMN-induced lung injury. 28 Evi- 
dence is accumulating that the bulk of the cellular 
injury and endothelial insult does not occur during 
ischemic preservation; a period of relative metabolic 
inertia, but during the reperfusion period. 8Conse- 
quently, our hypothesis was that NO would be 
maximally effective if applied during reperfusion, 
rather than during the preservation period. 8' 29 Nev- 
ertheless, the L-arginine/NO pathway has also been 
shown to be beneficial when activated uring the 
period of preservation, as shown in a recent study 
demonstrating anenhanced preservation of pulmo- 
nary grafts after supplementation f the preserva- 
tion solution with NO donors. 16' 3o 
The lung seems to be particularly susceptible to 
mediators eleased uring IR injury. 3' 31 This may be 
related to the fact that the pulmonary endothelium 
represents the largest vascular bed in the body. 
Reperfusion of one ischemic lung results in signifi- 
cant contralateral damage. 3' 31 Our results support 
that notion because function of the control native 
right lungs was worse after reperfusion of the left 
transplanted lung in our model, although not signif- 
icantly worse, than in the NO-treated native lungs. 
In addition, MPO values were significantly elevated 
in the control native lung compared with baseline 
values, confirming Bishop, Chi, and Cheney's find- 
ings 3 that unilateral lung reperfusion results in PMN 
accumulation i  the contralateral lung. Such an 
increase was not seen in the NO-treated native 
lungs. NO thus seems to inhibit PMN sequestration 
in the nontransplanted lung as well, conferring an 
obvious protection. 
The marked improvement in transalveolar gas 
exchange and oxygen content seen in the NO-group 
could be the result of improved ventilation-perfu- 
sion matching because NO has the singular property 
of preferentially dilating vascular segments located 
in ventilated areasY In contrast to the findings by 
Hillman and colleagues 32obtained in an adult re- 
spiratory distress yndrome model, in which Pao 2 
values returned to baseline and rebound pulmonary 
hypertension was seen when NO was precipitously 
discontinued, we found that the beneficial effect 
exerted by NO could still be documented 24 hours 
later. These data support a different mechanism of 
action than the pure vasodilative ffect of NO. 
Indeed, graft sequestration f PMNs was markedly 
inhibited by NO. This is probably a result of the 
well-described ability of NO to abrogate PMN ad- 
herence and diapedesis through the reperfused en- 
dothelium,& 29 protecting endothelial cells and the 
subjacent pneumocytes from PMN-generated oxy- 
gen-derived free radicals. The mechanism by which 
inhaled NO suppresses PMN adhesion may be re- 
lated to a downward regulation of adhesion mole- 
cule expression by NOY Inhibition of CDll-CD18 
PMN adhesion molecules by monoclonal ntibodies 
results in similar prevention of endothelial injury94 
The improvement of graft function is thus mainly a 
result of its antineutrophil activity; vasodilating 
properties of NO play only a secondary role. These 
findings are in agreement with those of Naka and 
coworkers, 3° who could not reproduce the same 
lung protection achieved with the NO-donor nitro- 
glycerin by adding hydralazine, a vasodilator, to the 
preservation solution. PMN accumulation was in- 
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hibited after nitroglycerin as well. A study of isch- 
emic and reperfused myocardium by Lefer and 
colleagues 29further supports our data. PMN accu- 
mulation was markedly diminished and blood flow 
was only modestly increased after administration of
an NO donor at the time of reperfusion. Examina- 
tion of the effects of short-term inhaled NO therapy 
on the transplanted lung after 24 hours of reperfu- 
sion enables us to support he hypothesis that NO 
does not merely delay the onset of pulmonary injury; 
rather, it seems to reduce the extent of cell injury. 
Although the precise role of endogenous NO as a 
modulator of the acute inflammatory response is 
still a matter of debate, there is also evidence for a 
harmful interaction between NO and superoxide in 
IR injury. 35 NO and superoxide can combine to 
form peroxynitrite anion and hydroxyl anion, both of 
which have potent oxidizing capabilities. 19This po- 
tential raised some reservations about the use of 
inhaled NO in the setting of IR injury. 3° Although 
we did not measure any reactive oxygen metabolites 
in this experiment, we did not observe any adverse 
effects from toxic oxygen intermediates. In the study 
of Eppinger and associates 35 on pulmonary IR, 
adverse ffects were seen early, after 30 minutes of 
reperfusion. After 4 hours, however, a protective 
effect was seen, and lung PMN content was signifi- 
cantly reduced, confirming our findings. 
Previous ex vivo studies by our group showed a 
reduction in IR-induced endothelial dysfunction af- 
ter supplementation with L-arginine or NO inhala- 
tion,17. 18 and we tested this hypothesis n vivo. As a 
consequence of the significant lung injury created in 
our model, a deleterious effect on endothelium- 
dependent relaxation was seen in both groups. Only 
a tendency toward better elaxation was observed in 
the NO group. One limitation of this study is that 
grafts were stored for 24 hours in normal saline 
solution. There is convincing evidence that normal 
saline solution should not be used as a preservation 
solution in vascular operations because it seriously 
damages the endothelium. 36 The seemingly irrevers- 
ible alteration of endothelial cell function observed 
after the long periods of IR set in our model could 
explain why the NO-induced reversibility of endo- 
thelial dysfunction seen in our previous tudies and 
those of others 17' 18, 37 was not found again. Relax- 
ation responses from right native lungs were also 
altered to a much lesser degree than in the trans- 
planted left lungs, however, confirming the notion 
that at reperfusion humoral factors damaging to the 
contralateral lung are released. 3' 31 In contrast with 
Kimblad, Sj6berg, and Steen's results, 14 endothelial 
dysfunction i our experiment did not correlate with 
PVR. Yet another limitation of our study is that 
data generated in segmental PAs rather than in 
microcirculatory vessels might not reflect the true 
vascular pulmonary impedance. 
Our findings have direct clinical implications. In 
an era of widespread organ shortage, use of inhaled 
NO to attenuate IR injury and obtain a lasting 
beneficial effect may lead to strategies by which 
more marginal organs can be used. In conclusion, 
we found that 4 hours of inhaled NO therapy started 
at reperfusion significantly attenuates IR injury, 
improving graft function as long as 24 hours after 
operation. The blunting of IR injury is probably 
mediated by a decrease in PMN adherence and 
sequestration i  both the transplanted and the con- 
tralateral lungs. These findings, combined with the 
lack of NO-related toxic side effects, make NO a 
suitable agent to use during the initial period of 
reperfusion after lung transplantation, specifically in 
cases where acute reperfusion phenomenon caused by 
poor graft quality or long ischemic periods is expected. 
We thank Chantal Verriest, Mich61e Gaillard and 
Bruno Baudet for their excellent technical assistance. 
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